We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MPI Technology Now Available to Medical Researchers in Australia

By HospiMedica International staff writers
Posted on 17 Jan 2017
Medical researchers in Australia now have access to a new imaging technology called Magnetic Particle Imaging (MPI) that can give researchers improved insight into organ and tissue function, with sensitivity comparable to that of nuclear medicine, the speed of Computed Tomography (CT), and the resolution of Magnetic Resolution Imaging (MRI).

MPI provides improved sensitivity, resolution, and contrast over existing imaging technologies, by using Super Paramagentic Iron Oxide (SPiO) nanoparticles to tag cells anywhere in the body, at any tissue depth. More...
MPI enables researchers to quantify what is actually happening in real time, and in vivo. In addition, MPI does not expose patients to ionizing radiation.

The new technology was part of a partnership agreement between AXT and Magnetic Insights. Momentum, the first MPI system can be used to generate quantitative images that analyze functional responses to drugs and treatments, in oncology, immunology, vascular function, and stem cell research, amongst others. The MPI technology could be used in the future to enable early detection and monitoring of neurovascular diseases such as stroke.

CEO of Magnetic Insight, Dr. Anna Christensen, said, “We are changing the landscape of diagnostic imaging with the impact of what MRI, PET and CT offered over 30 years ago. MPI complements many of the existing imaging modalities but also provides researchers and doctors levels of information that were not previously possible, all without radiation. We look forward to working with the team at AXT to bring this technology to Australia.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.